LC-MS/MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-01-14. Anything still debated is marked as such rather than presented as settled.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a PPARδ agonist. |
| Typical detection matrix | Urine | Most common sample for anti-doping analysis. |
| Common analytical method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry. |
| Common synonyms | GW501516, GSK-516, endurobol | Names found in research and fitness contexts. |
| Typical detection window | Variable | Depends on dose, route, and individual metabolism. |
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Rattlesnakes do not generally have bright or showy colors (reds, yellows, blues, etc.), instead relying on subtle earth tones that resemble the surrounding environment. Creases in the epidermal tissue connect the scales of rattlesnakes. When ingesting large prey, these creases can unfold, allowing the skin to expand to envelop a much greater volume. The skin appears to tightly stretch to accommodate the meal, but in reality, the skin is simply smoothing out from its creased state and is not under very high tension.
== Further reading == Noman, Ahmed; Shamsan, Mahmoud (23 August 2022). "Analysis: Origins of the Houthi supremacist ideology". commonspace.eu. Retrieved 3 July 2024. Sarhan, Mugahed; Saidin, Mohd Irwan Syazli (2022). "The Religious-Political Ideology of Houthis' Rebellion in Yemen: Theoretical Perspective of the Divine Right to Rule" (PDF). Archived from the original on 8 June 2025.
==== Nipple trauma ==== Cracked nipples, including nipple blisters and fissure, increase the nipple pain frequency and intensity during the first week postpartum. Traumas may break down the skin integrity of the nipple and serve as routes for infections. A common complication is mastitis due to bacterial infections.
The United States Seventh Army also played an integral role in supporting cultural diplomacy and strengthening international ties with Europe during the Cold War. The Seventh Army Symphony Orchestra was founded by Corporal Samuel Adler in Stuttgart, Germany as part of an effort by the US Army to demonstrate the common cultural heritage which existed in the United States, its European allies and the conquered nations in Europe during the Cold War period. The orchestra concertized extensively throughout Europe from 1952 until 1961 and performed works from the classical repertoire as well as contemporary compositions from the United States. Listed among the ensemble's earliest "musical ambassadors" were several young conductors including: John Ferritto, James Dixon, Kenneth Schermerhorn and Henry Lewis. In 1969, Jimi Hendrix performed an instrumental version of "The Star-Spangled Banner" at the Woodstock, distorting the tone while holding up peace symbols.
Sources: en.wikipedia.org
=== Career statistics === In a nine-season career, Mizell had a 90–88 record with a 3.85 ERA in 268 games, 230 of which were starts. He pitched 61 complete games, including 15 shutouts. Mizell allowed 654 earned runs and struck out 918, walking 680 in 1,528+2⁄3 innings pitched. He enjoyed his greatest success against the Pirates, against whom he went 14–7. Mizell also won 14 of his first 17 decisions against the Cubs, but Chicago did better against him later in his career, winning 12 of their final 16 decisions against him. Writing in 1971, Ray Owen, sports editor for The Southeast Missourian, called Mizell "one of the best strikeout hurlers around the National League scene for a span of ten years."
=== For evaluative well-being (life satisfaction) === Mental health is the strongest individual predictor of life satisfaction. Mental illness is associated with poorer well-being. In fact, mental health is the strongest determinant of quality of life at a later age. Studies have documented the relationship between anxiety and quality of life. The VOXEU analysis of happiness showed the principal determinants of an adult's life satisfaction to be income, parenting, family break up, mother's mental health and schooling. The factors that explain life satisfaction roughly map (negatively) to those factors that explain misery. They are first and foremost diagnosed depression/anxiety, which explains twice as much as the next factor, physical health (number of medical conditions), that explains just as much variance in subjective well-being between people, as income and whether someone is partnered. These factors count twice as much as each of whether someone is employed and whether they are a non-criminal, which in turn are 3 times as important as years of education. Overall, the best predictor of an adult's life satisfaction is their emotional health as a child as reported by the mother and child. It trumps factors like the qualifications that someone gets and their behaviour at 16 as reported by the mother. A child and therefore an adult's emotional health is most affected itself by a mother's mental health, which is just over twice as important as family income.
He remained director of the NIH facility until the NIH no longer funded such facilities and retired from his teaching position in 2006. The MS Facility continued to operate after funding stopped through the efforts of Watson, the Biochemistry and Chemistry Departments.
Sources: en.wikipedia.org
=== Secondary literature === Johns, Michael (5 November 1989). "Namibian Voters Deny Total Power to SWAPO. [Reprint]". barrysgovsites.blogspot.com. The Wall Street Journal, original publisher. Retrieved 7 November 2024. van der Hoog, Tycho (June 2022). "A New Chapter in Namibian History: Reflections on Archival Research". History in Africa. 49. Cambridge University Press: 389–414. doi:10.1017/hia.2021.12. hdl:1887/3303534. Retrieved 7 November 2024. An explainer of existing archives on SWAPO.
== Use == Dehydroascorbic acid has been used as a vitamin C dietary supplement. As a cosmetic ingredient, dehydroascorbic acid is used to enhance the appearance of the skin. It may be used in a process for permanent waving of hair and in a process for sunless tanning of skin. In a cell culture growth medium, dehydroascorbic acid has been used to assure the uptake of vitamin C into cell types that do not contain ascorbic acid transporters. As a pharmaceutical agent, some research has suggested that administration of dehydroascorbic acid may confer protection from neuronal injury following an ischemic stroke. The literature contains many reports on the antiviral effects of vitamin C, and one study suggests dehydroascorbic acid has stronger antiviral effects and a different mechanism of action than ascorbic acid. Solutions in water containing ascorbic acid and copper ions and/or peroxide, resulting in rapid oxidation of ascorbic acid to dehydroascorbic acid, have been shown to possess powerful but short-lived antimicrobial, antifungal, and antiviral properties, and have been used to treat gingivitis, periodontal disease, and dental plaque. A pharmaceutical product named Ascoxal is an example of such a solution used as a mouth rinse as an oral mucolytic and prophylactic agent against gingivitis. Ascoxal solution has also been tested with positive results as a treatment for recurrent mucocutaneous herpes, and as a mucolytic agent in acute and chronic pulmonary disease such as emphysema, bronchitis, and asthma by aerosol inhalation.
From 13 to 15 May 2026, the president of the United States Donald Trump made a state visit to China. This visit was Trump's second state visit to China, and the first to occur during his second presidency. Trump's first state visit to China occurred in November 2017. This trip was also the first by a U.S. president since Trump's visit in 2017. During the visit, Trump was received by CCP general secretary Xi Jinping at the Great Hall of the People, where the two leaders held talks. Xi announced the two sides had agreed to establish a Constructive Strategic and Stable Relationship. Following the talks, Xi and Trump visited the Temple of Heaven, the second US president to visit the Temple while in office after President Gerald Ford in 1975. Later, Xi hosted Trump for a dinner banquet at the Golden Room of the Great Hall of the People. Trump invited Xi for a state visit to the United States on 24 September 2026. At the second day of the visit on 15 May, Trump visited the Chinese leadership compound Zhongnanhai. The visit was the first of the four summits between Xi and Trump in 2026. It was reciprocated by a state visit by Xi Jinping to the United States in September 2026. Additionally, Trump is scheduled travel to China for APEC 2026 in November while Xi is scheduled to visit the United States for 2026 G20 Miami summit in December.
Sources: en.wikipedia.org
Yes, WADA prohibits cardarine as a PPARδ agonist. It appears on the prohibited list and can be detected in urine or blood. Athletes using it risk sanctions.
Detection usually uses liquid chromatography-tandem mass spectrometry after sample cleanup. Laboratories look for the parent compound or metabolites. The method requires validated reference standards and controls.
Legality varies by country. In many places it is an unapproved drug and cannot be legally sold for human consumption. Purchasing from online vendors carries legal and quality risks.
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.